We have previously identified ICAM1 as a potential target for melanoma.[6] The overexpression of ICAM1 in melanoma was subsequently clinically validated by the Cancer Genome Atlas Program (TCGA) and Human Protein Atlas (HPA) datasets. This evidence concerns the gene ICAM1 and melanoma.